WORCESTER, Mass., Aug. 12, 2011 (GLOBE NEWSWIRE) -- RXi Pharmaceuticals Corporation (Nasdaq:RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics, announced today that the Company's President and Chief Executive Officer, Mark J. Ahn, Ph.D., will present a corporate overview at the Wedbush Securities 2011 Life Sciences Management Access Conference on Wednesday, August 17, 2011 at 12:40pm ET at the Le Parker Meridien in New York City.
A live webcast of the presentation will be available from the "Investor Relations" section of the Company's website, www.rxipharma.com. A replay of the presentation will be available for 30 days.
About RXi Pharmaceuticals Corporation
RXi Pharmaceuticals Corporation (Nasdaq:RXII) is a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using targeted biotherapeutics. For more information, visit www.rxipharma.com.
The RXi Pharmaceuticals Corporation logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=10128
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about our and patent rights, our expectations, plans and prospects for the development of our products, and milestones and royalties that could become payable in connection with our recent licenses. These forward-looking statements about future expectations, plans and prospects of the development of the Company's products are subject to a number of risks, uncertainties and assumptions, including those identified under "Risk Factors" in the Company's most recently filed Annual Report on Form 10-K, Quarterly Report on Form 10-Q and in other filings the Company periodically makes with the SEC. Actual results may differ materially from those contemplated by these forward-looking statements. The Company does not undertake to update any of these forward-looking statements to reflect a change in its views or events or circumstances that occur after the date of this presentation.